Phase 2 Myelitis Clinical Trials
18 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–18 of 18 trials
Recruiting
Phase 2
A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.
OsteomyelitisPressure Ulcer, Stage IV
Biocomposites Ltd60 enrolled8 locationsNCT06283979
Recruiting
Phase 2
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Myalgic EncephalomyelitisChronic Fatigue Syndrome
Weill Medical College of Cornell University95 enrolled1 locationNCT04542161
Recruiting
Phase 1Phase 2
Ofatumumab in AQP4-IgG Seropositive NMOSD
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital5 enrolled1 locationNCT05504694
Recruiting
Phase 2
Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation
Poliomyelitis
PATH675 enrolled3 locationsNCT06895486
Recruiting
Phase 2
Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh
Poliomyelitis
PATH2,232 enrolled1 locationNCT05644184
Recruiting
Phase 2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder
Amgen15 enrolled19 locationsNCT05549258
Recruiting
Phase 2Phase 3
Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.12 enrolled21 locationsNCT05346354
Recruiting
Phase 2
Eculizumab For the Acute Attack of Neuromyelitis Optica Spectrum Disorder
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital110 enrolled1 locationNCT07184840
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers
Poliomyelitis
CanSino Biologics Inc.480 enrolled1 locationNCT06577298
Recruiting
Phase 2Phase 3
A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series
DiphtheriaPoliomyelitisHepatitis B+3 more
LG Chem1,186 enrolled1 locationNCT06947499
Recruiting
Phase 1Phase 2
Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines
Poliomyelitis
PATH2,400 enrolled2 locationsNCT06137664
Recruiting
Phase 2
Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
National Center of Neurology and Psychiatry, Japan30 enrolled1 locationNCT06952413
Recruiting
Phase 2Phase 3
TRI-ME: Trimetazidine to treat Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A double-blind, randomised, placebo-controlled efficacy trial
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Deakin University126 enrolled1 locationACTRN12625000095460
Recruiting
Phase 2Phase 3
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
Neuromyelitis Optica Spectrum Disorders
Shanghai Jiaolian Drug Research and Development Co., Ltd132 enrolled51 locationsNCT06413654
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
Neuromyelitis Optica Spectrum Disorders
Guangzhou JOYO Pharma Co., Ltd35 enrolled1 locationNCT06697535
Recruiting
Phase 2
Early Interferon-beta Treatment for West-Nile Virus Infection
West Nile VirusWest Nile Fever EncephalitisWest Nile Fever Myelitis+1 more
Tel-Aviv Sourasky Medical Center100 enrolled1 locationNCT06510426
Recruiting
Phase 2
Autologous Stem Cell Transplant in other Neuro-Inflammatory diseases
Neuromyelitis OpticaMyasthenia GravisCentral Nervous System Vasculitis
St Vincent's Hospital, Sydney20 enrolled1 locationACTRN12622000530729
Active
Phase 2
Immune response to two-dose fractional inactivated poliovirus vaccine administered at 4- and 8- month of age
Poliomyelitis
World Health Organization320 enrolled1 locationACTRN12610001046099